CHSJ

Curr Health Sci J, vol. 49, no. 1, 2023

Normal Coronary Arteries

[Case Report]

M.B. PINTOS-BELOTTO(1), O.A. CENTURION(1,2), C. CACERES(1), C. ROJAS-DURE(1), E.J. GALEANO(1)


(1)Division of Cardiovascular Medicine, Hospital de Clínicas, Asunción National University
(UNA), San Lorenzo, Paraguay;
(2)Department of Health Sciences Investigation, Sanatorio Metropolitano, Fernando de la Mora, Paraguay


Abstract:

Despite the beneficial effects of anti-COVID-19 vaccination, monitoring its safety has identified potential cardiac adverse events, mainly myocarditis and pericarditis. The case of a healthy 32-year-old male patient who developed acute myocardial infarction (AMI) 48 hours after the second dose of anti-COVID-19 mRNA vaccine (BNT162b2) is reported. This is the first reported case in the literature of an AMI associated to post-COVID-19 vaccination with mRNA vaccine (BNT162b2) in a healthy young adult without coronary risk factors and normal coronary arteries. Despite this adverse event, the continuation of the anti-COVID-19 vaccination campaign is encouraged due to the benefits it brings.


Keywords: ST-segment elevation acute myocardial infarction; COVID-19 vaccination; Inferior myocardial infarction.



Corresponding: Osmar Antonio Centurion, Division of Cardiovascular Medicine, Hospital de Clinicas, Av. Mariscal Lopez e/Coronel Cazal San Lorenzo, Paraguay, e-mail: osmarcenturion@hotmail.com


DOI 10.12865/CHSJ.49.01.14 - Download PDF
current issue cover Download cover
Download contents

Journal archive